Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Quita Highsmith"'
Autor:
Jeanne M. Regnante, Nicole Richie, Lola Fashoyin-Aje, Laura Lee Hall, Quita Highsmith, J'Aimee Louis, Kenneth Turner, Spencer Hoover, Simon Craddock Lee, Evelyn González, Erin Williams, Homer Adams, III, Coleman Obasaju, Ify Sargeant, Jovonni Spinner, Christopher Reddick, Marianne Gandee, Madeline Geday, Julie Dang, Rayneisha Watson, Moon S. Chen, Jr.
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Externí odkaz:
https://doaj.org/article/bcf3080c37f64eaa96be3f2b6b05c407
Autor:
Owen, Garrick, Ruben, Mesa, Andrea, Ferris, Edward S, Kim, Edith, Mitchell, Otis W, Brawley, John, Carpten, Keith D, Carter, Joseph, Coney, Robert, Winn, Stephanie, Monroe, Fabian, Sandoval, Edith, Perez, Mitzi, Williams, Evan, Grove, Quita, Highsmith, Nicole, Richie, Susan M, Begelman, Asha S, Collins, Jamie, Freedman, Melissa S, Gonzales, Gerren, Wilson
Publikováno v:
Ethn Dis
Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7808c19e2db8973cd712e0eb3dc87577
https://doi.org/10.18865/ed.32.1.61
https://doi.org/10.18865/ed.32.1.61
Autor:
Mohammed Suhail Chaudhry, Jessica Spahn, Shilpen Patel, Charles S. Fuchs, Jennifer Lauchle, Nikheel Kolatkar, Nicole Richie, Quita Highsmith, Meghan McKenzie, Ruma Bhagat
Publikováno v:
Nature medicine. 28(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e41c20cca4962d713d97dd33f3f8dd3
https://pubmed.ncbi.nlm.nih.gov/35668180
https://pubmed.ncbi.nlm.nih.gov/35668180
Autor:
Moon S. Chen, Ify Sargeant, Marianne Gandee, Nicole Richie, Julie H.T. Dang, Christopher Reddick, J'Aimee A. Louis, Homer Adams, Jovonni Spinner, Kenneth Turner, Rayneisha Watson, Quita Highsmith, Coleman K. Obasaju, Madeline Geday, Evelyn Gonzalez, Lola Fashoyin-Aje, Spencer C. Hoover, Jeanne M. Regnante, Simon J. Craddock Lee, Laura Lee Hall, Erin Fenske Williams
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7460171d4aa66a00c8405cd1713f347
http://europepmc.org/articles/PMC7005557
http://europepmc.org/articles/PMC7005557
Autor:
Jeanne M. Regnante, Lola Fashoyin-Aje, Ellen Miller Sonet, Quita Highsmith, Melissa Gonzales, Sandra Amaro, Amy Davis, Mary Stober Murray, Maimah Karmo, Barbara Bierer
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-084
Development of medicines and vaccines for COVID-19 amplified the need for all US communities to participate in research. This recognition spurred interest in adopting inclusive and equitable research practices across industry and the clinical researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d2476572ed85497349e0d45c9674eef
https://doi.org/10.1158/1538-7755.disp21-po-084
https://doi.org/10.1158/1538-7755.disp21-po-084
Autor:
Ruma Bhagat, Meghan McKenzie, Melissa Gonzales, Gerren Wilson, Nicole Richie, Quita Highsmith
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-006
Not all segments of the population have benefited equally from advances in science and medicine. Distinct populations continue to be understudied in science, underrepresented in research, and underserved by medicine. Multiple complex factors, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e54c705b101ece7349ecb898f2f5c71d
https://doi.org/10.1158/1538-7755.disp21-po-006
https://doi.org/10.1158/1538-7755.disp21-po-006
Autor:
Lorna H. McNeill, Nestor F. Esnaola, Kenneth Turner, Keerthi Gogineni, Moon S. Chen, Coleman K. Obasaju, Upal Basu Roy, Lola Fashoyin-Aje, Daniel G. Petereit, Olatunji B. Alese, Homer Adams, Luther T. Clark, Quita Highsmith, Simon J. Craddock Lee, Michelle Vichnin, Laura Lee Hall, Erin L Williams, Marvella E. Ford, Julie H.T. Dang, Evelyn Gonzalez, Ify Sargeant, Nicole Richie, Spencer C. Hoover, Jeanne M. Regnante
Publikováno v:
Journal of oncology practice. 15(4)
PURPOSE: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproportionately low despite a high prevalence of certain cancers in REMG populations. We aimed to identify notable practices used by leading US cancer centers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbc25d035171cd23517916990db7f94
https://pubmed.ncbi.nlm.nih.gov/30830833
https://pubmed.ncbi.nlm.nih.gov/30830833
Autor:
Lorna H. McNeill, Narjust Duma, Fabian Sandoval, Moon S. Chen, David E. Gerber, A. Ferris, Upal Basu Roy, Jeanne M. Regnante, Gerren Wilson, Quita Highsmith, Mary Stober Murray
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:PO-096
Disparities in clinical research are well-documented, and part of the broader health care disparities we see as a byproduct of systemic and institutional racism. COVID-19 vaccine and treatment development has greatly amplified the need for all commun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01a30cfb345246e7a1f1b7ae69cbd5b3
https://doi.org/10.1158/1538-7755.disp20-po-096
https://doi.org/10.1158/1538-7755.disp20-po-096
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:IA05-IA05
Health care disparities have been well documented for decades, and they continue to have a disproportionate impact on communities of color. Social determinants of health, lack of disease awareness, delayed diagnoses, and the inability to physically a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4cc0a968ec02e076d73117000315692
https://doi.org/10.1158/1538-7755.disp20-ia05
https://doi.org/10.1158/1538-7755.disp20-ia05
Autor:
Ify Sargeant, Simon J. Craddock Lee, Homer Adams, Spencer C. Hoover, Rayneisha Watson, Jeanne M. Regnante, Moon S. Chen, Coleman K. Obasaju, Nicole Richie, Marianne Gandee, Kenneth Turner, Lola Fashoyin-Aje, J'Aimee A. Louis, Madeline Geday, Quita Highsmith, Erin L Williams, Laura Lee Hall
Publikováno v:
Cancer Research. 79:LB-012
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. With the rise of precision medicine, it is critical that study populations in clinical research reflect the changing US demographics. Methods: Criteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf48a7f66f7785d8f3a2abe2b480ea89
https://doi.org/10.1158/1538-7445.am2019-lb-012
https://doi.org/10.1158/1538-7445.am2019-lb-012